NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$0.59
+0.04 (+6.51%)
As of Aug 14, 10:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
104.51M
Net Income
218.44M
Gross Margin
20.2%
Profit Margin
209.0%
Rev Growth
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 104.51M 401.7K 362.7K 344.3K
Gross Profit 21.13M 254.9K 230.1K 218.5K
Operating Income 241.62M 60.1K 48.3K 45.7K
Net Income 218.44M 41.8K 46.7K 41.5K
Gross Margin 20.2% 63.4% 63.4% 63.4%
Operating Margin 231.2% 15.0% 13.3% 13.3%
Profit Margin 209.0% 10.4% 12.9% 12.1%
Rev Growth +17.6% -6.2% -6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 261.6K 153.4K 184.7K 169.1K
Total Equity 1.60M 435.1K 422.0K 475.1K
D/E Ratio 0.16 0.35 0.44 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 245.77M 62.8K 66.4K 61.5K
Free Cash Flow 54.6K 52.4K 38.3K